Unlock regulatory insights with Watson. Learn More

Draft Guidance for Industry and Food and Drug Administration Staff: The Content of Investigational Device Exemption (IDE) and Premarket Approval (PMA) Applications for Low Glucose Suspend Device Systems

Docket Item Code D
Center CDRH